Communicating the benefits and harms of anticancer drugs

BMJ. 2023 Mar 29:380:623. doi: 10.1136/bmj.p623.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Communication*
  • Humans
  • Risk Assessment

Substances

  • Antineoplastic Agents